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Mixed medullary and papillary thyroid carcinoma is a rare 
clinical entity that should be considered in the differential 
diagnosis of thyroid nodules showing variable histological 
patterns, particularly in patients with a family history of 
thyroid malignancy. Around 40 cases of mixed medullary 
and papillary carcinoma of thyroid have been reported in 
literature.[1]
The WHO classification of thyroid tumours includes an 
entity called mixed medullary and follicular cell carcinoma 
which describes tumours showing morphological features 
of both, medullary carcinoma with immunoreactivity for 
calcitonin and follicular (or papillary) carcinoma with 
immunoreactivity for thyroglobulin. The medullary and 
papillary components can be seen as separate components 
or merge unperceptively within the same tumour.[2]
According to the WHO, prognosis of mixed medullary 
and papillary carcinoma depends on medullary component 
because medullary carcinoma is usually the predominant 
component of this tumour. It is important that mixed 
papillary and medullary carcinoma not be confused with 
papillary pattern of medullary carcinoma. To differentiate 
between the two, expression of calcitonin and CEA in 
medullary carcinoma and thyroglobulin in papillary 
component along with nuclear features is helpful.[3]
We received a thyroidectomy specimen in a 50-year-old 
male, with a history of thyroid nodule. Specimen was 
received in multiple pieces.
Grossly multiple grey white firm nodules were identified 
within the thyroid. Two small lymph nodes were also 
present. Microscopically, two separate and distinct tumours 
were identified. One tumour exhibited papillary pattern 
with classic nuclear features including powdery chromatin, 
nuclear grooves and intranuclear inclusions. The second 
showing solid nests with cells having hyperchormatic nuclei 
and salt and pepper chromatic pattern, and these cells were 
separated by homogenous eosinophilic material. Calcitonin 
was strongly positive in the second component confirming 
medullary carcinoma. Submitted lymph node was also 
positive for metastatic medullary carcinoma [Figure 1].
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Figure 1: (a) Classical papillary carcinoma, original H and 
E section ×10 view. (b) Medullary carcinoma, original H and 
E section ×20 view. (c) Metastatic medullary carcinoma in 
lymph node, original H and E section ×20 view. (d) Calcitonin 
expression in medullary carcinoma
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